Skip to main navigation

Educational Grants
Investigator Studies
Patient Support Services
Contact Us

About Coherus
Leadership
Board of Directors
Scientific Advisory Board
Commercial Advisory Committee
Contact Us

Toripalimab Program

Unique Development Process
FDA Approval Process

Products & Pipeline
UDENYCA^®
CIMERLI™ (RANIBIZUMAB-EQRN)
Coherus Solutions™
Medical Information

Investors

Join Our Team
Openings

Patient Support Services Contact Us

About Coherus
Immuno-oncology
- Toripalimab Program
Biosimilars
- Unique Development Process
- FDA Approval Process
Products and Pipeline
Investors
Join Our Team
- Job Openings
Patient Support Services

Image: Coherus Investors

Overview
News
Events & Presentations
Stock Information
Financials
Corporate Governance
Shareholder Services

Shareholder Tools

Print Page
RSS Feeds
Email Alerts

Events

Citi's 2023 18th Annual BioPharma Conference

Wednesday September 06, 2023 at 3:30 PM EDT

2023 Wells Fargo Healthcare Conference

Thursday Sep 07, 2023

H.C. Wainwright 25th Annual Global Investment Conference

Tuesday September 12, 2023 at 1:30 PM EDT

Presentations

Date	Title
Sep 05, 2023	Coherus Corporate Presentation – September 2023 3.7 MB

About Coherus
Immuno-oncology
- Toripalimab Program
Biosimilars
- Unique Development Process
- FDA Approval Process
Products and Pipeline
Investors
Join Our Team
- Openings
Privacy Notice
Contact Us

Coherus uses cookies on this website. They help us to know a little bit about you and how you use our website.

Privacy Notice
Site Map
Contact Us
Join Our Team

Copyright © 2023 Coherus BioSciences, Inc.

Please click the links below to download PDF versions of the following documents:

Download Brand.com

For more information, please visit brand.com.

Visit Brand.com

For more information, please visit UDENYCA.com.

Visit UDENYCA.com